Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COVID-19 in patients with rheumatological diseases treated with anti-TNF

16 Jun 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32546603
DOI: 10.1136/annrheumdis-2020-218171

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COVID-19 in patients with rheumatological diseases treated with anti-TNFPMID 32546603Read ↗

Clinical Features of Rheumatic Patients with Biologics Treatment Infected with COVID-19 in ChinaSemantic proximity Read ↗

Anti-TNF treatment in rheumatoid arthritis.Semantic proximity Read ↗

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 TreatmentSemantic proximity Read ↗

Silencing of immune activation with methotrexate in patients with COVID-19Semantic proximity Read ↗

TNF biology, pathogenic mechanisms and emerging therapeutic strategiesSemantic proximity Read ↗

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugsSemantic proximity Read ↗

Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in ScotlandSemantic proximity Read ↗

Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritisSemantic proximity Read ↗

Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?Semantic proximity Read ↗

No Increased Lethality in Covid-19 in Patients with Inflammatory Rheumatic Diseases Compared to the General Population - a Comparison of Two German Registries -Semantic proximity Read ↗

Cytokine release syndrome in severe COVID-19Semantic proximity Read ↗

Pharmacological Immunomodulation by Collagen-Polyvinylpyrrolidone or Pirfenidone Plays a Role in the Recovery of Patients with Severe COVID-19, Through a Similar Mechanism of Action Involving the JAK-STAT Signaling Pathway. Pilot StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.